Taiwan FDA registration e90fb0da3462008043f75cdf17ab7775
Frith Advanced Platelet Concentrate Separation Tube
TW: 福瑞絲進階型血小板濃縮液分離管
Taiwan·Risk Class 2·Taizong Biotechnology Co., Ltd.; Pusheng Co., Ltd. Nanke Factory·Registered Jun 03, 2017 – Jul 19, 2021CancelledRegistration details
- Analysis ID
- e90fb0da3462008043f75cdf17ab7775
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TCM BIOTECH INTERNATIONAL CORP.
Product details
- Intended Use
- This product uses vacuum blood collection to draw a small amount of peripheral blood from the patient, and centrifugally prepares platelet-rich plasma (PRP), which can be used by the original blood provider for orthopedic surgery sites.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Jun 03, 2017
- Expiry Date
- Jul 19, 2021
- Cancellation Date
- Sep 23, 2023
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Frith Advanced Platelet Concentrate Separation Tube in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e90fb0da3462008043f75cdf17ab7775 and manufactured by Taizong Biotechnology Co., Ltd.; Pusheng Co., Ltd. Nanke Factory. The authorized representative in Taiwan is TCM BIOTECH INTERNATIONAL CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices